RhumbLine Advisers’s Beam Therapeutics BEAM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.67M Sell
112,239
-18,960
-14% -$526K ﹤0.01% 1712
2025
Q4
$3.64M Sell
131,199
-12,629
-9% -$322K ﹤0.01% 1558
2025
Q3
$3.49M Sell
143,828
-7,544
-5% -$150K ﹤0.01% 1606
2025
Q2
$2.57M Buy
151,372
+10,168
+7% +$177K ﹤0.01% 1752
2025
Q1
$2.76M Buy
141,204
+14,971
+12% +$392K ﹤0.01% 1651
2024
Q4
$3.13M Sell
126,233
-872
-0.7% -$22.3K ﹤0.01% 1648
2024
Q3
$3.11M Sell
127,105
-5,464
-4% -$141K ﹤0.01% 1665
2024
Q2
$3.11M Buy
132,569
+23,565
+22% +$579K ﹤0.01% 1657
2024
Q1
$3.6M Buy
109,004
+4,792
+5% +$149K ﹤0.01% 1596
2023
Q4
$2.84M Sell
104,212
-1,284
-1% -$31.9K ﹤0.01% 1727
2023
Q3
$2.54M Buy
105,496
+10,412
+11% +$279K ﹤0.01% 1746
2023
Q2
$3.04M Buy
95,084
+7,136
+8% +$232K ﹤0.01% 1677
2023
Q1
$2.69M Buy
87,948
+1,408
+2% +$55.6K ﹤0.01% 1655
2022
Q4
$3.38M Buy
86,540
+1,583
+2% +$70.9K ﹤0.01% 1516
2022
Q3
$4.05M Buy
84,957
+8,763
+12% +$500K 0.01% 1355
2022
Q2
$2.95M Buy
76,194
+21,992
+41% +$874K ﹤0.01% 1551
2022
Q1
$3.11M Buy
54,202
+2,389
+5% +$157K ﹤0.01% 1584
2021
Q4
$4.13M Sell
51,813
-128
-0.2% -$11K 0.01% 1468
2021
Q3
$4.52M Buy
51,941
+3,210
+7% +$322K 0.01% 1415
2021
Q2
$6.27M Buy
48,731
+5,030
+12% +$401K 0.01% 1299
2021
Q1
$3.5M Sell
43,701
-2,536
-5% -$241K ﹤0.01% 1608
2020
Q4
$3.77M Buy
46,237
+9,204
+25% +$453K 0.01% 1518
2020
Q3
$912K Buy
37,033
+22,386
+153% +$555K ﹤0.01% 2031
2020
Q2
$410K Buy
14,647
+2,954
+25% +$63.7K ﹤0.01% 2434
2020
Q1
$210K Buy
+11,693
New +$254K ﹤0.01% 2562

Other funds holding BEAM